Hotline: +86-18022463983    020-85206863

United States Gravid Treatment Market Report & Forecast 2021-2027

Published Date: 2021-11-12   |   Pages: 105   |   Tables: 126   |  Medical Care

This report contains market size and forecasts of Gravid Treatment in United States, including the following market information:

United States Gravid Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

United States top five Gravid Treatment companies in 2020 (%)

The global Gravid Treatment market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The United States Gravid Treatment market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Gravid Treatment Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

United States Gravid Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Gravid Treatment Market Segment Percentages, By Type, 2020 (%)

Topical Products

Lasers

Microdermabrasion

Others

United States Gravid Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Gravid Treatment Market Segment Percentages, By Application, 2020 (%)

Hospitals

Clinics

Specialty Dermatology Centers

Home-use

Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gravid Treatment revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Gravid Treatment revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Laboratoires Expanscience

Clarins Group

Merz North America, Inc. (Merz Group)

E.T. Browne Drug

Cynosure

Syneron Medical Ltd.

Union-Swiss (Pty) Ltd.

Basq Skincare

Ellipse A/S

The Boppy Company

Helix BioMedix

Weleda AG

Dermaclara

Mama Mio US

Centre Light Solutions

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 Gravid Treatment Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 United States Gravid Treatment Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 United States Gravid Treatment Overall Market Size

2.1 United States Gravid Treatment Market Size: 2021 VS 2027

2.2 United States Gravid Treatment Revenue, Prospects & Forecasts: 2016-2027

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Gravid Treatment Players in United States Market

3.2 Top United States Gravid Treatment Companies Ranked by Revenue

3.3 United States Gravid Treatment Revenue by Companies

3.4 Top 3 and Top 5 Gravid Treatment Companies in United States Market, by Revenue in 2020

3.5 Companies Gravid Treatment Product Type

3.6 Tier 1, Tier 2 and Tier 3 Gravid Treatment Players in United States Market

3.6.1 List of Tier 1 Gravid Treatment Companies in United States

3.6.2 List of Tier 2 and Tier 3 Gravid Treatment Companies in United States

4 Sights by Type

4.1 Overview

4.1.1 By Type - United States Gravid Treatment Market Size Markets, 2021 & 2027

4.1.2 Topical Products

4.1.3 Lasers

4.1.4 Microdermabrasion

4.1.5 Others

4.2 By Type - United States Gravid Treatment Revenue & Forecasts

4.2.1 By Type - United States Gravid Treatment Revenue, 2016-2021

4.2.2 By Type - United States Gravid Treatment Revenue, 2022-2027

4.2.3 By Type - United States Gravid Treatment Revenue Market Share, 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - United States Gravid Treatment Market Size, 2021 & 2027

5.1.2 Hospitals

5.1.3 Clinics

5.1.4 Specialty Dermatology Centers

5.1.5 Home-use

5.1.6 Others

5.2 By Application - United States Gravid Treatment Revenue & Forecasts

5.2.1 By Application - United States Gravid Treatment Revenue, 2016-2021

5.2.2 By Application - United States Gravid Treatment Revenue, 2022-2027

5.2.3 By Application - United States Gravid Treatment Revenue Market Share, 2016-2027

6 Gravid Treatment Companies Profiles

6.1 Laboratoires Expanscience

6.1.1 Laboratoires Expanscience Company Details

6.1.2 Laboratoires Expanscience Business Overview

6.1.3 Laboratoires Expanscience Gravid Treatment Introduction

6.1.4 Laboratoires Expanscience Gravid Treatment Revenue in United States Market (2016-2021)

6.1.5 Laboratoires Expanscience Recent Developments

6.2 Clarins Group

6.2.1 Clarins Group Company Details

6.2.2 Clarins Group Business Overview

6.2.3 Clarins Group Gravid Treatment Introduction

6.2.4 Clarins Group Gravid Treatment Revenue in United States Market (2016-2021)

6.2.5 Clarins Group Recent Developments

6.3 Merz North America, Inc. (Merz Group)

6.3.1 Merz North America, Inc. (Merz Group) Company Details

6.3.2 Merz North America, Inc. (Merz Group) Business Overview

6.3.3 Merz North America, Inc. (Merz Group) Gravid Treatment Introduction

6.3.4 Merz North America, Inc. (Merz Group) Gravid Treatment Revenue in United States Market (2016-2021)

6.3.5 Merz North America, Inc. (Merz Group) Recent Developments

6.4 E.T. Browne Drug

6.4.1 E.T. Browne Drug Company Details

6.4.2 E.T. Browne Drug Business Overview

6.4.3 E.T. Browne Drug Gravid Treatment Introduction

6.4.4 E.T. Browne Drug Gravid Treatment Revenue in United States Market (2016-2021)

6.4.5 E.T. Browne Drug Recent Developments

6.5 Cynosure

6.5.1 Cynosure Company Details

6.5.2 Cynosure Business Overview

6.5.3 Cynosure Gravid Treatment Introduction

6.5.4 Cynosure Gravid Treatment Revenue in United States Market (2016-2021)

6.5.5 Cynosure Recent Developments

6.6 Syneron Medical Ltd.

6.6.1 Syneron Medical Ltd. Company Details

6.6.2 Syneron Medical Ltd. Business Overview

6.6.3 Syneron Medical Ltd. Gravid Treatment Introduction

6.6.4 Syneron Medical Ltd. Gravid Treatment Revenue in United States Market (2016-2021)

6.6.5 Syneron Medical Ltd. Recent Developments

6.7 Union-Swiss (Pty) Ltd.

6.7.1 Union-Swiss (Pty) Ltd. Company Details

6.7.2 Union-Swiss (Pty) Ltd. Business Overview

6.7.3 Union-Swiss (Pty) Ltd. Gravid Treatment Introduction

6.7.4 Union-Swiss (Pty) Ltd. Gravid Treatment Revenue in United States Market (2016-2021)

6.7.5 Union-Swiss (Pty) Ltd. Recent Developments

6.8 Basq Skincare

6.8.1 Basq Skincare Company Details

6.8.2 Basq Skincare Business Overview

6.8.3 Basq Skincare Gravid Treatment Introduction

6.8.4 Basq Skincare Gravid Treatment Revenue in United States Market (2016-2021)

6.8.5 Basq Skincare Recent Developments

6.9 Ellipse A/S

6.9.1 Ellipse A/S Company Details

6.9.2 Ellipse A/S Business Overview

6.9.3 Ellipse A/S Gravid Treatment Introduction

6.9.4 Ellipse A/S Gravid Treatment Revenue in United States Market (2016-2021)

6.9.5 Ellipse A/S Recent Developments

6.10 The Boppy Company

6.10.1 The Boppy Company Company Details

6.10.2 The Boppy Company Business Overview

6.10.3 The Boppy Company Gravid Treatment Introduction

6.10.4 The Boppy Company Gravid Treatment Revenue in United States Market (2016-2021)

6.10.5 The Boppy Company Recent Developments

6.11 Helix BioMedix

6.11.1 Helix BioMedix Company Details

6.11.2 Helix BioMedix Business Overview

6.11.3 Helix BioMedix Gravid Treatment Introduction

6.11.4 Helix BioMedix Gravid Treatment Revenue in United States Market (2016-2021)

6.11.5 Helix BioMedix Recent Developments

6.12 Weleda AG

6.12.1 Weleda AG Company Details

6.12.2 Weleda AG Business Overview

6.12.3 Weleda AG Gravid Treatment Introduction

6.12.4 Weleda AG Gravid Treatment Revenue in United States Market (2016-2021)

6.12.5 Weleda AG Recent Developments

6.13 Dermaclara

6.13.1 Dermaclara Company Details

6.13.2 Dermaclara Business Overview

6.13.3 Dermaclara Gravid Treatment Introduction

6.13.4 Dermaclara Gravid Treatment Revenue in United States Market (2016-2021)

6.13.5 Dermaclara Recent Developments

6.14 Mama Mio US

6.14.1 Mama Mio US Company Details

6.14.2 Mama Mio US Business Overview

6.14.3 Mama Mio US Gravid Treatment Introduction

6.14.4 Mama Mio US Gravid Treatment Revenue in United States Market (2016-2021)

6.14.5 Mama Mio US Recent Developments

6.15 Centre Light Solutions

6.15.1 Centre Light Solutions Company Details

6.15.2 Centre Light Solutions Business Overview

6.15.3 Centre Light Solutions Gravid Treatment Introduction

6.15.4 Centre Light Solutions Gravid Treatment Revenue in United States Market (2016-2021)

6.15.5 Centre Light Solutions Recent Developments

7 Conclusion

8 Appendix

8.1 Note

8.2 Examples of Clients

8.3 Author Details

8.4 Disclaimer

List of Tables

Table 1. Gravid Treatment Market Opportunities & Trends in United States Market

Table 2. Gravid Treatment Market Drivers in United States Market

Table 3. Gravid Treatment Market Restraints in United States Market

Table 4. Key Players of Gravid Treatment in United States Market

Table 5. Top Gravid Treatment Players in United States Market, Ranking by Revenue (2019)

Table 6. United States Gravid Treatment Revenue by Companies, (US$, Mn), 2016-2021

Table 7. United States Gravid Treatment Revenue Share by Companies, 2016-2021

Table 8. Companies Gravid Treatment Product Type

Table 9. List of Tier 1 Gravid Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 Gravid Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. By Type – United States Gravid Treatment Revenue, (US$, Mn), 2021 & 2027

Table 12. By Type - United States Gravid Treatment Revenue (US$, Mn), 2016-2021

Table 13. By Type - United States Gravid Treatment Revenue (US$, Mn), 2022-2027

Table 14. By Application – United States Gravid Treatment Revenue, (US$, Mn), 2021 VS 2027

Table 15. By Application - United States Gravid Treatment Revenue (US$, Mn), 2016-2021

Table 16. By Application - United States Gravid Treatment Revenue (US$, Mn), 2022-2027

Table 17. Laboratoires Expanscience Company Details

Table 18. Laboratoires Expanscience Business Overview

Table 19. Laboratoires Expanscience Gravid Treatment Product

Table 20. Laboratoires Expanscience Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 21. Laboratoires Expanscience Recent Developments

Table 22. Clarins Group Company Details

Table 23. Clarins Group Business Overview

Table 24. Clarins Group Gravid Treatment Product

Table 25. Clarins Group Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 26. Clarins Group Recent Developments

Table 27. Merz North America, Inc. (Merz Group) Company Details

Table 28. Merz North America, Inc. (Merz Group) Business Overview

Table 29. Merz North America, Inc. (Merz Group) Gravid Treatment Product

Table 30. Merz North America, Inc. (Merz Group) Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 31. Merz North America, Inc. (Merz Group) Recent Developments

Table 32. E.T. Browne Drug Company Details

Table 33. E.T. Browne Drug Business Overview

Table 34. E.T. Browne Drug Gravid Treatment Product

Table 35. E.T. Browne Drug Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 36. E.T. Browne Drug Recent Developments

Table 37. Cynosure Company Details

Table 38. Cynosure Business Overview

Table 39. Cynosure Gravid Treatment Product

Table 40. Cynosure Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 41. Cynosure Recent Developments

Table 42. Syneron Medical Ltd. Company Details

Table 43. Syneron Medical Ltd. Business Overview

Table 44. Syneron Medical Ltd. Gravid Treatment Product

Table 45. Syneron Medical Ltd. Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 46. Syneron Medical Ltd. Recent Developments

Table 47. Union-Swiss (Pty) Ltd. Company Details

Table 48. Union-Swiss (Pty) Ltd. Business Overview

Table 49. Union-Swiss (Pty) Ltd. Gravid Treatment Product

Table 50. Union-Swiss (Pty) Ltd. Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 51. Union-Swiss (Pty) Ltd. Recent Developments

Table 52. Basq Skincare Company Details

Table 53. Basq Skincare Business Overview

Table 54. Basq Skincare Gravid Treatment Product

Table 55. Basq Skincare Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 56. Basq Skincare Recent Developments

Table 57. Ellipse A/S Company Details

Table 58. Ellipse A/S Business Overview

Table 59. Ellipse A/S Gravid Treatment Product

Table 60. Ellipse A/S Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 61. Ellipse A/S Recent Developments

Table 62. The Boppy Company Company Details

Table 63. The Boppy Company Business Overview

Table 64. The Boppy Company Gravid Treatment Product

Table 65. The Boppy Company Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 66. The Boppy Company Recent Developments

Table 67. Helix BioMedix Company Details

Table 68. Helix BioMedix Business Overview

Table 69. Helix BioMedix Gravid Treatment Product

Table 70. Helix BioMedix Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 71. Helix BioMedix Recent Developments

Table 72. Weleda AG Company Details

Table 73. Weleda AG Business Overview

Table 74. Weleda AG Gravid Treatment Product

Table 75. Weleda AG Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 76. Weleda AG Recent Developments

Table 77. Dermaclara Company Details

Table 78. Dermaclara Business Overview

Table 79. Dermaclara Gravid Treatment Product

Table 80. Dermaclara Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 81. Dermaclara Recent Developments

Table 82. Mama Mio US Company Details

Table 83. Mama Mio US Business Overview

Table 84. Mama Mio US Gravid Treatment Product

Table 85. Mama Mio US Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 86. Mama Mio US Recent Developments

Table 87. Centre Light Solutions Business Overview

Table 88. Centre Light Solutions Company Details

Table 89. Centre Light Solutions Gravid Treatment Product

Table 90. Centre Light Solutions Gravid Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 91. Centre Light Solutions Recent Developments

List of Figures

Figure 1. Gravid Treatment Segment by Type

Figure 2. Gravid Treatment Segment by Application

Figure 3. United States Gravid Treatment Market Overview: 2020

Figure 4. United States Gravid Treatment Market Size: 2021 VS 2027 (US$, Mn)

Figure 5. United States Gravid Treatment Revenue, 2016-2027 (US$, Mn)

Figure 6. The Top 3 and 5 Players Market Share by Gravid Treatment Revenue in 2020

Figure 7. By Type - United States Gravid Treatment Revenue Market Share, 2016-2027

Figure 8. By Application - United States Gravid Treatment Revenue Market Share, 2016-2027

Figure 9. Laboratoires Expanscience Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 10. Clarins Group Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 11. Merz North America, Inc. (Merz Group) Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 12. E.T. Browne Drug Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 13. Cynosure Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 14. Syneron Medical Ltd. Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 15. Union-Swiss (Pty) Ltd. Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 16. Basq Skincare Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 17. Ellipse A/S Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 18. The Boppy Company Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 19. Helix BioMedix Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 20. Weleda AG Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 21. Dermaclara Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 22. Mama Mio US Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 23. Centre Light Solutions Gravid Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Our Clients